Cargando…

Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report

BACKGROUND: The relative effectiveness of vitamin K antagonists compared with novel oral anticoagulants in treating pulmonary embolism remains unclear. Recent trials comparing the efficacy of vitamin K antagonists with factor Xa inhibitors for the treatment of pulmonary emboli have been non-inferior...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rankin, James, Nagar, Menachem, Crosby, Jonathan, Toomari, Nojan, Pietras, Richard, Ben-Zur, Uri M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135742/ https://www.ncbi.nlm.nih.gov/pubmed/27912791 http://dx.doi.org/10.1186/s13256-016-1135-9

Ejemplares similares

Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy
por: Yaghoubian, Jonathan M., et al.
Publicado: (2017)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2018)

Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings
por: Ghazvinian, Raein, et al.
Publicado: (2020)

Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism
por: Ghazvinian, R., et al.
Publicado: (2018)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Medications that interact with direct-acting oral anticoagulant exposure
por: de Vries, T. A. C., et al.
Publicado: (2021)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians
por: Peacock, W. Frank, et al.
Publicado: (2016)

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal
por: Maadarani, Ossama, et al.
Publicado: (2019)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

The use of direct acting oral anticoagulants in patients with COVID-19 infection
por: Aly, Ragia, et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
por: Górnicki, Tomasz, et al.
Publicado: (2023)

A Case of Isolated Unilateral Right Renal Vein Thrombosis Associated with Bilateral Pulmonary Embolism Treated with Rivaroxaban a Direct-Acting Oral Anticoagulant
por: Matta, Anthony, et al.
Publicado: (2019)

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
por: Dubinski, Daniel, et al.
Publicado: (2021)

Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
por: Rose, Adam J., et al.
Publicado: (2021)

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022)

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Direct-Acting Oral Anticoagulants: A Resident-Based Workshop to Improve Knowledge and Confidence
por: Anderson, Irsk, et al.
Publicado: (2020)

Direct-acting Anticoagulants in Chronic Coronary Syndromes
por: Sorbets, Emmanuel, et al.
Publicado: (2020)

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
por: Gómez-Outes, Antonio, et al.
Publicado: (2014)

Antiphospholipid antibodies in pulmonary embolism treated with direct oral anticoagulants: Prevalence data from unselected consecutive patients
por: Justinussen, Tummas, et al.
Publicado: (2023)

Pulmonary embolism in patients with COVID-19 pneumonia on adequate oral anticoagulation
por: Di Tano, Giuseppe, et al.
Publicado: (2021)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
por: Generalova, Daria, et al.
Publicado: (2020)

Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
por: Al Rowily, Abdulrhman, et al.
Publicado: (2023)

Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study
por: Samaranayake, Chinthaka B., et al.
Publicado: (2021)

New Oral Anticoagulants in the Treatment of Pulmonary Embolism: Efficacy, Bleeding Risk, and Monitoring
por: Rudd, Kelly M., et al.
Publicado: (2013)

Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct‐Acting Antiviral Treatment Failure in Patients With Hepatitis C?
por: Piecha, Felix, et al.
Publicado: (2019)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Direct oral anticoagulant therapy as an alternative to surgery for the treatment of a patient with a floating thrombus in the ascending aorta and pulmonary embolism
por: Toyama, Masashi, et al.
Publicado: (2018)

Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis
por: Nery, Filipe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4fppck2khm35qas36ojqd8og8m